Medical experts are catching up to what the natural family planning community suspected all along …
But some good news for PCOS sufferers was announced this week as researchers at the French National Institute of Health and Medical Research reported that the cause of the syndrome may have been discovered at last: fetal exposure to an excess of anti-Mullerian hormone in utero.
“[The scientists] injected excess anti-Müllerian hormone into pregnant mice. As their female offspring grew up, they displayed many of the hallmarks of polycystic ovary syndrome, including later puberty, infrequent ovulation, delays in falling pregnant, and fewer offspring. The excess hormone seemed to trigger this effect by overstimulating a set of brain cells that raise the level of testosterone.
The team were able to reverse this effect in the mice using cetrorelix, an IVF drug routinely used to control women’s hormones. After treatment with this drug, the mice stopped showing symptoms of polycystic ovary syndrome.
The team is now planning a clinical trial of cetrorelix in women with the condition, which they hope to start before the end of the year. “It could be an attractive strategy to restore ovulation and eventually increase the pregnancy rate in these women,” says Giacobini.”
While this news is exciting, it isn’t totally unexpected for Natural Procreative Technology (NaPro Technology) physicians, who have long suspected that PCOS is caused by a hormonal imbalance, and have worked to address the root causes of the issue by treating it as such. While the majority of mainstream healthcare providers have long offered little but the birth control pill to counteract the side effects of PCOS, the news from France this week offers hope to millions of women around the world who want a cure for this serious condition – and not just a temporary band-aid solution like the Pill.
One thing is certain: it is wonderful to see PCOS finally receiving the attention that it deserves, and to see the researchers working on the disease finally making progress on what may be a real cure. Hopefully one day millions of women around the world and those who love them will benefit from the work of the French researchers announced this week.
Support Aleteia takes a minute
If you’re reading this article, it’s precisely thanks to your generosity and to that of many other people like you that make possible the evangelization project of Aleteia. Here some numbers:
- 20 million of users around the world read Aleteia.org every month.
- Aleteia is published daily in eight languages: French, English, Arabic, Italian, Spanish, Portuguese, Polish and Slovenian.
- Each month, our readers view more than 50 million pages.
- Nearly 4 million people follow Aleteia’s social media pages.
- Each month, we publish 2,450 articles and around 40 videos.
- All of this work is carried out by 60 people working full-time and approximately 400 other collaborators (writers, journalists, translators, photographers…).
As you can imagine, behind these numbers there is a big effort. We need your support so we can keep offering this service of evangelization to everyone, regardless of where they live or what they can afford to pay.
Support Aleteia from as little as $1 – and only takes a minute. Thank you!